CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 203 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2023. The put-call ratio across all filers is 1.16 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,060 | -22.9% | 74,865 | -20.3% | 0.00% | 0.0% |
| Q1 2024 | $3,971 | -75.2% | 93,948 | -75.1% | 0.00% | -80.0% |
| Q4 2023 | $16,020 | +403.0% | 377,862 | +159.0% | 0.01% | +150.0% |
| Q3 2023 | $3,185 | -23.7% | 145,910 | +11.1% | 0.00% | -33.3% |
| Q2 2023 | $4,175 | -71.5% | 131,342 | -78.1% | 0.00% | -57.1% |
| Q1 2023 | $14,660 | +1.8% | 601,054 | +31.6% | 0.01% | +16.7% |
| Q4 2022 | $14,402 | -99.5% | 456,615 | +367.2% | 0.01% | +100.0% |
| Q3 2022 | $2,762,000 | +3632.4% | 97,735 | +3371.9% | 0.00% | – |
| Q2 2022 | $74,000 | -69.0% | 2,815 | -58.7% | 0.00% | – |
| Q1 2022 | $239,000 | – | 6,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 65,679,781 | $2,685,646,245 | 57.02% |
| Twin Securities, Inc. | 416,657 | $17,037,105 | 13.40% |
| Sand Grove Capital Management LLP | 919,023 | $37,578,850 | 10.99% |
| Perceptive Advisors | 10,794,876 | $441,402,480 | 10.63% |
| P SCHOENFELD ASSET MANAGEMENT LP | 796,440 | $32,566,432 | 7.87% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,353,694 | $96,242,547 | 4.60% |
| Avoro Capital Advisors LLC | 7,539,547 | $308,292,077 | 4.11% |
| Melqart Asset Management (UK) Ltd | 1,099,229 | $44,947,474 | 3.72% |
| Paradigm Biocapital Advisors LP | 2,330,508 | $95,294,472 | 3.65% |
| WATER ISLAND CAPITAL LLC | 766,933 | $31,360 | 3.33% |